Biocon Sdn. Bhd. (Company No. 201101002193)July 5, 2019

FDA 483 - Biocon Sdn. Bhd. (Company No. 201101002193) - July 05, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Biocon Sdn. Bhd. (Company No. 201101002193)

Record Details

An FDA inspection of Biocon Sdn Bhd in Iskandar Puteri, Malaysia, revealed significant deficiencies in quality control, investigations, aseptic processing, and laboratory controls. The firm failed to adhere to established procedures for deviation management, CAPA effectiveness, and data integrity, with several issues noted as repeat observations. These findings indicate systemic problems in maintaining drug product quality and sterility.

Company: Biocon Sdn. Bhd. (Company No. 201101002193)
Inspection Date: July 5, 2019
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
People: Katherine D Adams
Maryam Tabatabaie (issuing_officer)
Linda F. Murphy (SVP Consulting & Operations)

Open in Dashboard

ID · 1b2622e7-7b28-4a27-9335-58c9238ad92d